<?xml version="1.0"?> <template xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="openEHR/v1/Template">   <id>6fe7e1a8-5951-4191-b450-4b0fe1286e59</id>   <name>Antiemetics Peds Order Panel</name>   <description>     <lifecycle_state>Initial</lifecycle_state>     <details>       <purpose/>       <use/>       <misuse/>     </details>     <other_details>       <item>         <key>MetaDataSet:Sample Set </key>         <value>Template metadata sample set </value>       </item>       <item>         <key>Acknowledgements</key>         <value/>       </item>       <item>         <key>Business Process Level</key>         <value/>       </item>       <item>         <key>Care setting</key>         <value/>       </item>       <item>         <key>Client group</key>         <value/>       </item>       <item>         <key>Clinical Record Element</key>         <value/>       </item>       <item>         <key>Copyright</key>         <value/>       </item>       <item>         <key>Issues</key>         <value/>       </item>       <item>         <key>Owner</key>         <value/>       </item>       <item>         <key>Sign off</key>         <value/>       </item>       <item>         <key>Speciality</key>         <value/>       </item>       <item>         <key>User roles</key>         <value/>       </item>     </other_details>   </description>   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">     <items>       <item>         <key>CKT.Clinical Guidance</key>         <value>&lt;p&gt;DimenhyDRINATE oral and IV dosing based on weight 0.5 to 1 mg/kg/dose recommended. Max 50 mg/dose. Do not use concurrently with diphenhydramine.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;Dosing by weight categories:&lt;/p&gt;&lt;p&gt;2.4-4.7 Kg: 3 mg&lt;/p&gt;&lt;p&gt;4.8-7 kg: 6 mg&lt;/p&gt;&lt;p&gt;7.1-10.5 kg: 9 mg&lt;/p&gt;&lt;p&gt;10.6-13.5 kg: 12 mg&lt;/p&gt;&lt;p&gt;13.6-17 kg: 15mg&lt;/p&gt;&lt;p&gt;17.1-22.5kg: 22.5mg&lt;/p&gt;&lt;p&gt;22.6-38 kg: 25mg&lt;/p&gt;&lt;p&gt;Greater than 38 kg: 50mg&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;Suggested Dosing interval is every 6 hours&lt;/p&gt;</value>       </item>     </items>   </annotations>   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1 and name/value=&apos;Clinical Guidance #1&apos;]">     <items>       <item>         <key>CKT.Clinical Guidance</key>         <value>&lt;p&gt;DimenhyDRINATE suppository dosing by age. Dose every 8-12 hours&lt;/p&gt;&lt;p&gt;Age 2-8 years: 12.5-25 mg&lt;/p&gt;&lt;p&gt;Age 8-12 years: 25-50 mg&lt;/p&gt;&lt;p&gt;Age greater than12 years: 50 mg&lt;/p&gt;</value>       </item>     </items>   </annotations>   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1 and name/value=&apos;Clinical Guidance #2&apos;]">     <items>       <item>         <key>CKT.Clinical Guidance</key>         <value>&lt;p&gt;Ondansetron&lt;/p&gt;&lt;p&gt;0.1 mg/kg/dose recommended. Suggested max 4 mg/dose; doses above 4 mg may be used in chemotherapy and radiation related nausea (see pediatric oncology antiemetic order set). Avoid in patients with long-QT syndrome and avoid combining with other QT-prolonging meds (consider a baseline and followup ECG if combining them). Ondanstron is the preferred antiemetic for nausea and vomiting in gastroenteritis.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;Weight based dosing for oral ondansetron:&lt;/p&gt;&lt;p&gt;&lt;em&gt;4-6 kg: 0.5 mg&lt;/em&gt;&lt;/p&gt;&lt;p&gt;&lt;em&gt;6.1-7.9 kg: 0.8 mg&lt;/em&gt;&lt;/p&gt;&lt;p&gt;&lt;em&gt;8-11.9 kg: 1 mg&lt;/em&gt;&lt;/p&gt;&lt;p&gt;&lt;em&gt;12-24.9 kg: 2 mg&lt;/em&gt;&lt;/p&gt;&lt;p&gt;&lt;em&gt;&amp;gt; 25 mg: 4 mg&lt;/em&gt;&lt;/p&gt;&lt;p&gt;&lt;em&gt;&amp;nbsp;&lt;/em&gt;&lt;/p&gt;&lt;p&gt;&lt;em&gt;Suggested dosing interval is every 8 hours &lt;/em&gt;&lt;/p&gt;</value>       </item>     </items>   </annotations>   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1 and name/value=&apos;Clinical Guidance #2&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">     <items>       <item>         <key>CKT.Clinical Guidance</key>         <value>&lt;p&gt;&lt;em&gt;Weight based dosing for IV ondansetron&lt;/em&gt;&lt;/p&gt;&lt;p&gt;&lt;em&gt;Infants greater than or equal to 1 month and Children less than or equal to 12 years: &lt;/em&gt;&lt;/p&gt;&lt;p&gt;&lt;em&gt;&amp;nbsp;&amp;nbsp; IV: &amp;nbsp;less than or equal to 40 kg: 0.1 mg/kg &lt;/em&gt;&lt;/p&gt;&lt;p&gt;&lt;em&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; &amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;Greater than 40 kg: 4 mg &lt;/em&gt;&lt;/p&gt;&lt;p&gt;&lt;em&gt;Adolescents Greater than 12 years: IV: 4 mg&lt;/em&gt;&lt;/p&gt;&lt;p&gt;&lt;em&gt;Note: Use oral route whenever possible due to increased risk of arrhythmia with IV ondansetron &lt;/em&gt;&lt;/p&gt;</value>       </item>     </items>   </annotations>   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1 and name/value=&apos;Clinical Guidance #3&apos;]">     <items>       <item>         <key>CKT.Clinical Guidance</key>         <value>&lt;p&gt;&lt;em&gt;Due to high cost, recommend reserving ondansetron DISINTEGRATING tab to&lt;/em&gt;&lt;em&gt; patients with difficulty swallowing tablets or capsules OR &lt;/em&gt;&lt;em&gt;actively vomiting patients without an IV&lt;/em&gt;&lt;/p&gt;</value>       </item>     </items>   </annotations>   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]"><items><item><key>Technical.ï»© Technical Traceability</key><value>{~AHSID~6fe7e1a8-5951-4191-b450-4b0fe1286e59~NAME~Antiemetics Peds Order Panel}</value></item></items></annotations><definition xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" name="Order Panel: Antiemetics Peds">     <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Antiemetics"/>     <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items">       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="907f470f-caf1-432f-8f59-6720d969177d" concept_name="PHARM dimenhyDRINATE 3 mg/mL ORAL liquid Order" max="1" path="/items" name="dimenhyDRINATE Oral liquid 3 mg/mL; 3 mg PO ONCE"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="907f470f-caf1-432f-8f59-6720d969177d" concept_name="PHARM dimenhyDRINATE 3 mg/mL ORAL liquid Order" max="1" path="/items" name="dimenhyDRINATE Oral liquid 3 mg/mL; 6 mg PO ONCE"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="907f470f-caf1-432f-8f59-6720d969177d" concept_name="PHARM dimenhyDRINATE 3 mg/mL ORAL liquid Order" max="1" path="/items" name="dimenhyDRINATE Oral liquid 3 mg/mL; 9 mg PO ONCE"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="907f470f-caf1-432f-8f59-6720d969177d" concept_name="PHARM dimenhyDRINATE 3 mg/mL ORAL liquid Order" max="1" path="/items" name="dimenhyDRINATE Oral liquid 3 mg/mL; 12 mg PO ONCE"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="907f470f-caf1-432f-8f59-6720d969177d" concept_name="PHARM dimenhyDRINATE 3 mg/mL ORAL liquid Order" max="1" path="/items" name="dimenhyDRINATE Oral liquid 3 mg/mL; 15 mg PO ONCE"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="907f470f-caf1-432f-8f59-6720d969177d" concept_name="PHARM dimenhyDRINATE 3 mg/mL ORAL liquid Order" max="1" path="/items" name="dimenhyDRINATE Oral liquid 3 mg/mL; 22.5 mg PO ONCE"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="907f470f-caf1-432f-8f59-6720d969177d" concept_name="PHARM dimenhyDRINATE 3 mg/mL ORAL liquid Order" max="1" path="/items" name="dimenhyDRINATE Oral liquid 3 mg/mL; 25 mg PO ONCE"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="907f470f-caf1-432f-8f59-6720d969177d" concept_name="PHARM dimenhyDRINATE 3 mg/mL ORAL liquid Order" max="1" path="/items" name="dimenhyDRINATE Oral liquid 3 mg/mL; 50 mg PO ONCE"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="518ff2cd-715c-4eff-99e5-6678da8a95ac" concept_name="PHARM dimenhyDRINATE Tablet Order" max="1" path="/items" name="dimenhyDRINATE Tablet; 25 mg PO ONCE"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="518ff2cd-715c-4eff-99e5-6678da8a95ac" concept_name="PHARM dimenhyDRINATE Tablet Order" max="1" path="/items" name="dimenhyDRINATE Tablet; 25 mg PO ONCE #1"/>     </Item>     <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="Clinical Guidance #1">       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="4b92a969-5e3f-4eed-9f4a-1ee889f2b8b1" concept_name="PHARM dimenhyDRINATE Suppository Order" max="1" path="/items" name="dimenhyDRINATE Suppository; 12.5 mg RECTALLY ONCE for nausea/vomiting"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="4b92a969-5e3f-4eed-9f4a-1ee889f2b8b1" concept_name="PHARM dimenhyDRINATE Suppository Order" max="1" path="/items" name="dimenhyDRINATE Suppository; 25 mg RECTALLY ONCE for nausea/vomiting"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="4b92a969-5e3f-4eed-9f4a-1ee889f2b8b1" concept_name="PHARM dimenhyDRINATE Suppository Order" max="1" path="/items" name="dimenhyDRINATE Suppository; 50 mg RECTALLY ONCE for nausea/vomiting"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="4b92a969-5e3f-4eed-9f4a-1ee889f2b8b1" concept_name="PHARM dimenhyDRINATE Suppository Order" max="1" path="/items" name="dimenhyDRINATE Suppository; 12.5 mg RECTALLY every__(8) hours PRN for nausea/vomiting"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="4b92a969-5e3f-4eed-9f4a-1ee889f2b8b1" concept_name="PHARM dimenhyDRINATE Suppository Order" max="1" path="/items" name="dimenhyDRINATE Suppository; 25 mg RECTALLY every__(8) hours PRN for nausea/vomiting"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="4b92a969-5e3f-4eed-9f4a-1ee889f2b8b1" concept_name="PHARM dimenhyDRINATE Suppository Order" max="1" path="/items" name="dimenhyDRINATE Suppository; 50 mg RECTALLY every__(8) hours PRN for nausea/vomiting"/>     </Item>     <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="Clinical Guidance #2">       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="11f7a892-e0e9-4c35-b3b6-29f67917b8c8" concept_name="PHARM ondansetron 0.8 mg/mL ORAL liquid Order" max="1" path="/items" name="ondansetron 0.8 mg/mL ORAL liquid; 0.5 mg PO ONCE"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="11f7a892-e0e9-4c35-b3b6-29f67917b8c8" concept_name="PHARM ondansetron 0.8 mg/mL ORAL liquid Order" max="1" path="/items" name="ondansetron 0.8 mg/mL ORAL liquid; 0.8 mg PO ONCE"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="11f7a892-e0e9-4c35-b3b6-29f67917b8c8" concept_name="PHARM ondansetron 0.8 mg/mL ORAL liquid Order" max="1" path="/items" name="ondansetron 0.8 mg/mL ORAL liquid; 1 mg PO ONCE"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="11f7a892-e0e9-4c35-b3b6-29f67917b8c8" concept_name="PHARM ondansetron 0.8 mg/mL ORAL liquid Order" max="1" path="/items" name="ondansetron 0.8 mg/mL ORAL liquid; 2 mg PO ONCE"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="11f7a892-e0e9-4c35-b3b6-29f67917b8c8" concept_name="PHARM ondansetron 0.8 mg/mL ORAL liquid Order" max="1" path="/items" name="ondansetron 0.8 mg/mL ORAL liquid; 4 mg PO ONCE"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="ceb70162-69de-42da-b231-05ff8dbc8eae" concept_name="PHARM ondansetron Tablet Order" max="1" path="/items" name="ondansetron tablet"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="ceb70162-69de-42da-b231-05ff8dbc8eae" concept_name="PHARM ondansetron Tablet Order" max="1" path="/items" name="ondansetron tablet #1"/>       <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="87878269-d8fc-4410-93ed-5d6495a412a3" concept_name="PHARM ondansetron, preservative free Injection Order" max="1" path="/items" name="ondansetron, preservative free Injection; (0.1 mg/kg) ____ mg IV ONCE"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="87878269-d8fc-4410-93ed-5d6495a412a3" concept_name="PHARM ondansetron, preservative free Injection Order" max="1" path="/items" name="ondansetron, preservative free Injection; 4 mg IV ONCE"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="87878269-d8fc-4410-93ed-5d6495a412a3" concept_name="PHARM ondansetron, preservative free Injection Order" max="1" path="/items" name="ondansetron, preservative free Injection; (0.1 mg/kg)  ___ mg IV every 8 hours PRN for nausea/vomiting"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="87878269-d8fc-4410-93ed-5d6495a412a3" concept_name="PHARM ondansetron, preservative free Injection Order" max="1" path="/items" name="ondansetron, preservative free Injection; 4 mg IV every 8 hours PRN for nausea/vomiting"/>     </Item>     <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="Clinical Guidance #3">       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="a7014313-c3f3-4fc4-9077-6d796f649b99" concept_name="PHARM ondansetron ODT tablet Order" max="1" path="/items" name="ondansetron ODT tablet; 2 mg PO every 8 hours PRN for nausea/vomiting"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="a7014313-c3f3-4fc4-9077-6d796f649b99" concept_name="PHARM ondansetron ODT tablet Order" max="1" path="/items" name="ondansetron ODT tablet; 4 mg PO every 8 hours PRN for nausea/vomiting"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="a7014313-c3f3-4fc4-9077-6d796f649b99" concept_name="PHARM ondansetron ODT tablet Order" max="1" path="/items" name="ondansetron ODT tablet; 8 mg PO every 8 hours PRN for nausea/vomiting"/>     </Item>   </definition>   <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.adhoc.v1">     <digest id="MD5-CAM-1.0.1">8AE70853975A75254E6D39A8DE3652AF</digest>   </integrity_checks>   <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1">     <digest id="MD5-CAM-1.0.1">4B2F0F6CD593E442DA9C30277A3EA9CF</digest>   </integrity_checks>   <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1">     <digest id="MD5-CAM-1.0.1">AD8DFB192E67715F0D9E11E95E674AD0</digest>   </integrity_checks>   <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1">     <digest id="MD5-CAM-1.0.1">230A8D964017E1FD7AC82EBDEE0202A6</digest>   </integrity_checks> </template>